Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients

IntroductionAnemia, a frequently encountered issue among cancer patients undergoing chemotherapy, is regrettably underappreciated despite its prevalence and profound impact on their well-being. Chemotherapy-induced anemia (CIA) diminishes the quality of life, causing fatigue, breathlessness, and a d...

Full description

Saved in:
Bibliographic Details
Main Authors: MV Chandrakanth, Vivek Agarwala, Pranav Sopory, Himadri Nayak, Purvish M. Parikh, Minakshi Roy, Rajib De, Pradeep Narayan, Anjuli Tuladhar Barai, Kaustav Mandal, Moinak Basu, Subhabrata Kumar, Rajdeep Singh Uppal, Syed Mujtaba Hussain Naqvi, Rohit Desai
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1418327/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589815895293952
author MV Chandrakanth
Vivek Agarwala
Pranav Sopory
Himadri Nayak
Purvish M. Parikh
Minakshi Roy
Rajib De
Pradeep Narayan
Anjuli Tuladhar Barai
Kaustav Mandal
Moinak Basu
Subhabrata Kumar
Rajdeep Singh Uppal
Syed Mujtaba Hussain Naqvi
Rohit Desai
author_facet MV Chandrakanth
Vivek Agarwala
Pranav Sopory
Himadri Nayak
Purvish M. Parikh
Minakshi Roy
Rajib De
Pradeep Narayan
Anjuli Tuladhar Barai
Kaustav Mandal
Moinak Basu
Subhabrata Kumar
Rajdeep Singh Uppal
Syed Mujtaba Hussain Naqvi
Rohit Desai
author_sort MV Chandrakanth
collection DOAJ
description IntroductionAnemia, a frequently encountered issue among cancer patients undergoing chemotherapy, is regrettably underappreciated despite its prevalence and profound impact on their well-being. Chemotherapy-induced anemia (CIA) diminishes the quality of life, causing fatigue, breathlessness, and a decline in the performance status. However, correcting anemia can lead to notable improvements in these parameters. Notably, darbepoetin alpha (DA) has shown efficacy in addressing anemia in this context. This real-world study aims to evaluate the efficacy of DA in the treatment of CIA among Indian cancer patients.MethodsThis single-center retrospective study assessed the effectiveness of DA in treating CIA among advanced/metastatic solid tumor patients on palliative myelosuppressive therapy. The study measured the change in hemoglobin levels after DA administration as the primary outcome, with secondary outcomes including impact on blood transfusion dependence, changes in anemia-related symptoms, and occurrence of adverse events.ResultsA total of 523 patients, with a median age of 55, were included in the study. Patients were categorized based on cancer site, type of chemotherapy, response to therapy, and DA doses. A significant mean increase of 2.28 gm/dl in hemoglobin (Hb) levels from baseline to post-DA administration was observed (8.56±0.45 to 10.84±0.92; 26.6%; P<.001). Each sub-group revealed a significant enhancement of mean hemoglobin from baseline to the end of treatment. Significant improvements were noted from baseline in fatigue, and dyspnea. Adverse drug reactions included hypertension (5.4%), deep vein thrombosis (2.9%), and arrhythmias (0.8%).DiscussionDA demonstrates impressive efficacy and safety in managing CIA, leading to substantial improvements in mean hemoglobin levels in palliative setting. This has the potential to reduce the need for blood transfusions and enhance the quality of life for patients.
format Article
id doaj-art-0bb59ac6c1994904853b89c45dcb3f09
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-0bb59ac6c1994904853b89c45dcb3f092025-01-24T07:13:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011510.3389/fonc.2025.14183271418327Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patientsMV Chandrakanth0Vivek Agarwala1Pranav Sopory2Himadri Nayak3Purvish M. Parikh4Minakshi Roy5Rajib De6Pradeep Narayan7Anjuli Tuladhar Barai8Kaustav Mandal9Moinak Basu10Subhabrata Kumar11Rajdeep Singh Uppal12Syed Mujtaba Hussain Naqvi13Rohit Desai14Department of Medical Oncology, Narayana Hospital, Kolkata, IndiaDepartment of Medical Oncology, Narayana Hospital, Kolkata, IndiaOncology Cluster, Dr Reddy’s Laboratories, Hyderabad, IndiaDepartment of Medical Oncology, Rabindranath Tagore Hospital, Kolkata, IndiaDepartment of Clinical Hematology, Mahatma Gandhi Medical College & Hospital, Jaipur, IndiaDepartment of Medical Oncology, Rabindranath Tagore Hospital, Kolkata, IndiaDepartment of Medical Oncology, Narayana Hospital, Kolkata, IndiaDepartment of Medical Oncology, Rabindranath Tagore Hospital, Kolkata, IndiaDepartment of Medical Oncology, Rabindranath Tagore Hospital, Kolkata, IndiaDepartment of Medical Oncology, Narayana Hospital, Kolkata, IndiaDepartment of Medical Oncology, Narayana Hospital, Kolkata, IndiaDepartment of Medical Oncology, Narayana Hospital, Kolkata, IndiaHematology Cluster, Dr Reddy’s Laboratories, Hyderabad, IndiaOncology Cluster, Dr Reddy’s Laboratories, Hyderabad, IndiaOncology Cluster, Dr Reddy’s Laboratories, Hyderabad, IndiaIntroductionAnemia, a frequently encountered issue among cancer patients undergoing chemotherapy, is regrettably underappreciated despite its prevalence and profound impact on their well-being. Chemotherapy-induced anemia (CIA) diminishes the quality of life, causing fatigue, breathlessness, and a decline in the performance status. However, correcting anemia can lead to notable improvements in these parameters. Notably, darbepoetin alpha (DA) has shown efficacy in addressing anemia in this context. This real-world study aims to evaluate the efficacy of DA in the treatment of CIA among Indian cancer patients.MethodsThis single-center retrospective study assessed the effectiveness of DA in treating CIA among advanced/metastatic solid tumor patients on palliative myelosuppressive therapy. The study measured the change in hemoglobin levels after DA administration as the primary outcome, with secondary outcomes including impact on blood transfusion dependence, changes in anemia-related symptoms, and occurrence of adverse events.ResultsA total of 523 patients, with a median age of 55, were included in the study. Patients were categorized based on cancer site, type of chemotherapy, response to therapy, and DA doses. A significant mean increase of 2.28 gm/dl in hemoglobin (Hb) levels from baseline to post-DA administration was observed (8.56±0.45 to 10.84±0.92; 26.6%; P<.001). Each sub-group revealed a significant enhancement of mean hemoglobin from baseline to the end of treatment. Significant improvements were noted from baseline in fatigue, and dyspnea. Adverse drug reactions included hypertension (5.4%), deep vein thrombosis (2.9%), and arrhythmias (0.8%).DiscussionDA demonstrates impressive efficacy and safety in managing CIA, leading to substantial improvements in mean hemoglobin levels in palliative setting. This has the potential to reduce the need for blood transfusions and enhance the quality of life for patients.https://www.frontiersin.org/articles/10.3389/fonc.2025.1418327/fullchemotherapy-induced anemiacancer-related anemiadarbepoetin alfapalliative cancer caresupportive cancer careretrospective analysis
spellingShingle MV Chandrakanth
Vivek Agarwala
Pranav Sopory
Himadri Nayak
Purvish M. Parikh
Minakshi Roy
Rajib De
Pradeep Narayan
Anjuli Tuladhar Barai
Kaustav Mandal
Moinak Basu
Subhabrata Kumar
Rajdeep Singh Uppal
Syed Mujtaba Hussain Naqvi
Rohit Desai
Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients
Frontiers in Oncology
chemotherapy-induced anemia
cancer-related anemia
darbepoetin alfa
palliative cancer care
supportive cancer care
retrospective analysis
title Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients
title_full Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients
title_fullStr Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients
title_full_unstemmed Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients
title_short Cresp®: transforming the landscape of chemotherapy-induced anemia - a comprehensive retrospective real-world analysis in 523 Indian patients
title_sort cresp r transforming the landscape of chemotherapy induced anemia a comprehensive retrospective real world analysis in 523 indian patients
topic chemotherapy-induced anemia
cancer-related anemia
darbepoetin alfa
palliative cancer care
supportive cancer care
retrospective analysis
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1418327/full
work_keys_str_mv AT mvchandrakanth cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT vivekagarwala cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT pranavsopory cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT himadrinayak cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT purvishmparikh cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT minakshiroy cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT rajibde cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT pradeepnarayan cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT anjulituladharbarai cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT kaustavmandal cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT moinakbasu cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT subhabratakumar cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT rajdeepsinghuppal cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT syedmujtabahussainnaqvi cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients
AT rohitdesai cresptransformingthelandscapeofchemotherapyinducedanemiaacomprehensiveretrospectiverealworldanalysisin523indianpatients